Latest News & Features
Americas
California has become the first US state to ban pay-for-delay deals in the pharmaceutical industry. 9 October 2019
Big Pharma
The English High Court has sided with pharmaceutical company Vectura and Novartis-owned Sandoz in a passing off lawsuit brought by rival GSK. 8 October 2019
Americas
The US Court of Appeals for the Federal Circuit last week reversed a Patent Trial and Appeal Board decision, which found that claims in an OSI Pharmaceuticals patent for cancer treatment were obvious. 7 October 2019
Big Pharma
A US subsidiary of Chinese genome sequencing company BGI has filed a patent infringement counterclaim against Illumina. 4 October 2019
Americas
LSX World Congress USA brings life sciences investment and partnering to Boston. 4 October 2019
Americas
Goldfinch Bio, a US company focused on developing treatments for kidney disease, has agreed to license a cannabinoid receptor 1 antibody from Japanese pharmaceutical manufacturer Takeda. 4 October 2019
Big Pharma
Novartis has teamed with Microsoft to launch a new artificial intelligence innovation lab, which it says has the potential to “transform” and “reimagine” medicine. 3 October 2019
Americas
The US Patent and Trademark Office (USPTO) has granted a new CRISPR-Cas9 patent to the University of California (UC), the University of Vienna and Emmanuelle Charpentier, marking the fifth consecutive week that the USPTO has approved a new patent in their CRISPR portfolio. 3 October 2019
Americas
Canadian pharmaceutical company Bausch Health is suing Sandoz for patent infringement over its notice of intent to release a generic version of Xifaxan, Bausch’s irritable bowel syndrome drug. 3 October 2019
Americas
Evolve BioSystems and the University of California have jointly sued Abbott Laboratories for patent infringement over a soon-to-be-launched probiotic product. 3 October 2019